Friday, March 31, 2023


Machine learning models rank predictive risks for Alzheimer’s disease

Study suggests genetic risk outweighs age in adults over 65.

Study reveals how the brain makes sense of changing environmental cues

How the brain's 'internal compass' works?

Gene therapy boosts cold shock protein to protect mice against neurodegenerative disease

Gene therapy increases levels of 'cold shock protein' to protect mice from prion disease.

Depression in Alzheimer’s has different risk factors than those without the disease

Alzheimer's disease is more common in older adults with dementia.

T cells’ role in Alzheimer’s suggests a new treatment strategy

Drug development possibilities for brain diseases linked to tau protein.

Targeting Alzheimer’s using AI

Model tested on tens of thousands of routine brain scans spotted disease risk with 90% accuracy.

We still don’t know which factors most affect cognitive decline with age

It highlights the knowledge gap needed to reduce cognitive decline.

Study finds a correlation between neurodegeneration in obese people and Alzheimer’s disease

Obesity-related neurodegeneration mimics Alzheimer’s disease.

New blood test could detect Alzheimer’s disease 3.5 years before clinical diagnosis

The study supports the idea that components in the human blood can modulate the formation of new brain cells.

This protein could be a possible biomarker for the very early stages of Alzheimer’s

Blood-based markers may reveal Alzheimer's disease ten years before symptoms show.

FDA approved Leqembi for Alzheimer’s disease treatment

This treatment option is the latest therapy to target.

Why are women more likely to get Alzheimer’s?

A clue to the molecular cause of Alzheimer’s.

Recent Stories